ArticleJournal of robotic surgery2026
Feasibility and early safety outcomes of robotic-assisted bariatric surgery using the Versius
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic assistance has been increasingly incorporated into bariatric surgery. However, data regarding newer modular robotic-assisted platforms such as the Versius® Surgical Robotic System remain limited, particularly in developing healthcare settings. To evaluate the feasibility, safety, and short-term outcomes of robotic-assisted bariatric surgery (RABS) using the Versius® system in a high-volume bariatric center. A retrospective analysis was conducted on 200 robotic-assisted bariatric procedures performed between December 2021 and December 2024. Procedures included primary and revisional bariatric operations. The Versius® system was used as a robotic-assisted platform, with laparoscopic stapling, energy devices, and suction performed through an assistant port. Demographic data, operative metrics, complications, length of stay, and six-month postoperative outcomes were analyzed descriptively. The mean BMI was 43.85 ± 6.7 kg/m². Procedures included Sleeve Gastrectomy (n = 132), One-Anastomosis Gastric Bypass (n = 25), Roux-en-Y Gastric Bypass (n = 22), and Revisional Surgery (n = 21). Docking time decreased from 17 to 7 min, and console time stabilized after 30–40 cases. There were no conversions to open or laparoscopic surgery. The six-month morbidity rate was 1.5% (Clavien-Dindo Grade I–IIIb). RABS using the Versius® platform is safe and feasible in this series, demonstrating a manageable learning curve. While the platform is adoptable in emerging healthcare settings, comparative studies are required to establish its clinical and cost advantages over standard laparoscopy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.